![](/img/cover-not-exists.png)
Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease
Meijer, Esther, Drenth, Joost P.H., d'Agnolo, Hedwig, Casteleijn, Niek F., de Fijter, Johan W., Gevers, Tom J., Kappert, Peter, Peters, Dorien J.M., Salih, Mahdi, Soonawala, Darius, Spithoven, Edwin MVolume:
63
Language:
english
Journal:
American Journal of Kidney Diseases
DOI:
10.1053/j.ajkd.2013.10.011
Date:
March, 2014
File:
PDF, 255 KB
english, 2014